Literature DB >> 28502058

Reversible cerebral vasoconstriction syndrome and antivitamin K anticoagulation: challenges of an unusual association.

Amina Nasri1, Malek Mansour2, Amel Kacem3, Jamel Zaouali2, Ridha Mrissa2.   

Abstract

Entities:  

Keywords:  Headache Attack; International Normalize Ratio; Magnetic Resonance Angiography; Nimodipine; Vascular Calcification

Mesh：

Substances：

Year:  2017        PMID： 28502058     DOI： 10.1007/s10072-017-2990-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  8 in total

1.  Severe reversible cerebral vasoconstriction syndrome after taking a product for slimming.

Authors:  Carlo Piantadosi; Loredana Bove; Marco Minnetti; Mauro Brogi
Journal:  Neurol Sci       Date:  2016-08-01       Impact factor: 3.307

Review 2.  Warfarin and Vascular Calcification.

Authors:  Timothy J Poterucha; Samuel Z Goldhaber
Journal:  Am J Med       Date:  2015-12-20       Impact factor: 4.965

Review 3.  Reversible cerebral vasoconstriction syndrome.

Authors:  Anne Ducros
Journal:  Lancet Neurol       Date:  2012-10       Impact factor: 44.182

Review 4.  Systematic review of reversible cerebral vasoconstriction syndrome.

Authors:  Ahsan Sattar; Georgios Manousakis; Matthew B Jensen
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-10

5.  Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats.

Authors:  Leon J Schurgers; Henri M H Spronk; Berry A M Soute; Paul M Schiffers; Jo G R DeMey; Cees Vermeer
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

Review 6.  Thunderclap Headache.

Authors:  Todd J Schwedt
Journal:  Continuum (Minneap Minn)       Date:  2015-08

7.  Impaired vascular reactivity in patients with chronic kidney disease.

Authors:  Fabian Tetzner; Alexandra Scholze; Antje Wittstock; Walter Zidek; Martin Tepel
Journal:  Am J Nephrol       Date:  2007-10-24       Impact factor: 3.754

8.  Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.

Authors:  Sipanan Thamratnopkoon; Paweena Susantitaphong; Monravee Tumkosit; Pisut Katavetin; Khajohn Tiranathanagul; Kearkiat Praditpornsilpa; Somchai Eiam-Ong
Journal:  Nephron       Date:  2016-12-13       Impact factor: 2.847
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.